Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Hyaluronan Oligosaccharides as a Potential Anticancer Therapeutic

Author(s): Bryan P. Toole, Shibnath Ghatak and Suniti Misra

Volume 9, Issue 4, 2008

Page: [249 - 252] Pages: 4

DOI: 10.2174/138920108785161569

Price: $65

Abstract

Hyaluronan (HA) polysaccharide has differential effects on cells depending on polymer size. One of the more exciting findings is that small chains or oligosaccharides of HA (6-18 sugar units), but not large polymers, will kill many types of cancer cells by triggering apoptosis while leaving normal cells unaffected. Even chemoresistant cells become drug-sensitive when co-treated with HA oligosaccharides. Overall, these observations form the basis for new anticancer therapeutics.

Keywords: Cancer, metastasis, CD44, signaling, apoptosis


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy